457 related articles for article (PubMed ID: 30696380)
1. Integrative analysis identifies potential DNA methylation biomarkers for pan-cancer diagnosis and prognosis.
Ding W; Chen G; Shi T
Epigenetics; 2019 Jan; 14(1):67-80. PubMed ID: 30696380
[TBL] [Abstract][Full Text] [Related]
2. DNA Methylation Markers for Pan-Cancer Prediction by Deep Learning.
Liu B; Liu Y; Pan X; Li M; Yang S; Li SC
Genes (Basel); 2019 Oct; 10(10):. PubMed ID: 31590287
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation markers for diagnosis and prognosis of common cancers.
Hao X; Luo H; Krawczyk M; Wei W; Wang W; Wang J; Flagg K; Hou J; Zhang H; Yi S; Jafari M; Lin D; Chung C; Caughey BA; Li G; Dhar D; Shi W; Zheng L; Hou R; Zhu J; Zhao L; Fu X; Zhang E; Zhang C; Zhu JK; Karin M; Xu RH; Zhang K
Proc Natl Acad Sci U S A; 2017 Jul; 114(28):7414-7419. PubMed ID: 28652331
[TBL] [Abstract][Full Text] [Related]
4. Large-scale analysis of
Croes L; Beyens M; Fransen E; Ibrahim J; Vanden Berghe W; Suls A; Peeters M; Pauwels P; Van Camp G; Op de Beeck K
Clin Epigenetics; 2018; 10():51. PubMed ID: 29682089
[TBL] [Abstract][Full Text] [Related]
5. Colon cancer-specific diagnostic and prognostic biomarkers based on genome-wide abnormal DNA methylation.
Wang Y; Zhang M; Hu X; Qin W; Wu H; Wei M
Aging (Albany NY); 2020 Nov; 12(22):22626-22655. PubMed ID: 33202377
[TBL] [Abstract][Full Text] [Related]
6. Integrative analysis of DNA methylation and gene expression reveals hepatocellular carcinoma-specific diagnostic biomarkers.
Cheng J; Wei D; Ji Y; Chen L; Yang L; Li G; Wu L; Hou T; Xie L; Ding G; Li H; Li Y
Genome Med; 2018 May; 10(1):42. PubMed ID: 29848370
[TBL] [Abstract][Full Text] [Related]
7. Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC).
Pu W; Wang C; Chen S; Zhao D; Zhou Y; Ma Y; Wang Y; Li C; Huang Z; Jin L; Guo S; Wang J; Wang M
Clin Epigenetics; 2017; 9():129. PubMed ID: 29270239
[TBL] [Abstract][Full Text] [Related]
8. Roadmap of DNA methylation in breast cancer identifies novel prognostic biomarkers.
de Almeida BP; Apolónio JD; Binnie A; Castelo-Branco P
BMC Cancer; 2019 Mar; 19(1):219. PubMed ID: 30866861
[TBL] [Abstract][Full Text] [Related]
9. [Genome-wide analysis of DNA methylation in prostate cancer using the technology of Infinium HumanMethylation450 BeadChip (HM450)].
Babalyan KA; Sultanov R; Generozov EV; Zakharzhevskaya NB; Sharova EI; Peshkov MN; Vasilev AO; Govorov AV; Pushkar DY; Prilepskaya EA; Danilenko SA; Babikova EA; Larin AK; Govorun VM
Vopr Onkol; 2016; 62(1):122-32. PubMed ID: 30444590
[TBL] [Abstract][Full Text] [Related]
10. Hypermethylation of CpG islands in primary and metastatic human prostate cancer.
Yegnasubramanian S; Kowalski J; Gonzalgo ML; Zahurak M; Piantadosi S; Walsh PC; Bova GS; De Marzo AM; Isaacs WB; Nelson WG
Cancer Res; 2004 Mar; 64(6):1975-86. PubMed ID: 15026333
[TBL] [Abstract][Full Text] [Related]
11. Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers.
Liu X; Peng Y; Wang J
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32412047
[TBL] [Abstract][Full Text] [Related]
12. Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma.
Shen S; Wang G; Shi Q; Zhang R; Zhao Y; Wei Y; Chen F; Christiani DC
Clin Epigenetics; 2017; 9():88. PubMed ID: 28852427
[TBL] [Abstract][Full Text] [Related]
13. The
Ibrahim J; Op de Beeck K; Fransen E; Peeters M; Van Camp G
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31752152
[TBL] [Abstract][Full Text] [Related]
14. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
15. Exploration of DNA methylation markers for diagnosis and prognosis of patients with endometrial cancer.
Ying J; Xu T; Wang Q; Ye J; Lyu J
Epigenetics; 2018; 13(5):490-504. PubMed ID: 29912667
[TBL] [Abstract][Full Text] [Related]
16. Genome-wide DNA methylation profiling and identification of potential pan-cancer and tumor-specific biomarkers.
Ibrahim J; Op de Beeck K; Fransen E; Peeters M; Van Camp G
Mol Oncol; 2022 Jun; 16(12):2432-2447. PubMed ID: 34978357
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities:
Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M
Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424
[TBL] [Abstract][Full Text] [Related]
18. Integrative Analysis of DNA Methylation and Gene Expression to Determine Specific Diagnostic Biomarkers and Prognostic Biomarkers of Breast Cancer.
Zhang M; Wang Y; Wang Y; Jiang L; Li X; Gao H; Wei M; Zhao L
Front Cell Dev Biol; 2020; 8():529386. PubMed ID: 33365308
[No Abstract] [Full Text] [Related]
19. CpG methylation signature predicts prognosis in breast cancer.
Du T; Liu B; Wang Z; Wan X; Wu Y
Breast Cancer Res Treat; 2019 Dec; 178(3):565-572. PubMed ID: 31520283
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic biomarkers of common urological cancers based on aberrant DNA methylation.
Peng D; Ge G; Xu Z; Ma Q; Shi Y; Zhou Y; Gong Y; Xiong G; Zhang C; He S; He Z; Li X; Ci W; Zhou L
Epigenomics; 2018 Sep; 10(9):1189-1199. PubMed ID: 30182734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]